Correlation between parametric imaging using contrast ultrasound and the histological differentiation of hepatocellular carcinoma

Hepatology Research

Volumn 38, Issue 3, 2008, Pages 273-280

  Sugimoto, Katsutoshi ^a   Moriyasu, Fuminori ^a   Kamiyama, Naohisa ^b   Yamada, Masahiko ^a   Iijima, Hiroko ^c  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOSHIBA MEDICAL SYSTEMS CORPORATION   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Contrast enhanced ultrasound; Hepatocellular carcinoma; Parametric imaging

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER PERFUSION; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; TUMOR DIFFERENTIATION;

EID: 38849096979     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00259.x     Document Type: Article

References (33)

1. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997; 26 (3 Suppl 1): 34S-8S.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-50.
3. Colombo M. Hepatocellular carcinoma. J Hepatol 1992; 15: 225-36.
4. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998; 27: 273-8.
5. Trinchet JC, Beaugrand M. Treatment of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1997; 27: 756-65.
6. Bruix J. Treatment of hepatocellular carcinoma. Hepatology 1997; 25: 259-62.
7. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998; 129: 643-53.
8. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma: Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001; 35: 421-30.
9. Nicolau C, Catala V, Vilana R et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14: 1092-9.
10. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996; 24: 807-12.
11. Kanematsu M, Hoshi H, Takao H, Sugiyama Y. Abdominal wall tumor seeding at sonographically guided needle-core aspiration biopsy of hepatocellular carcinoma. AJR 1997; 169: 1198-9.
12. Takamori R, Wong LL, Dang C, Wong L. Needletract implantation from hepatocellular cancer: Is needle biopsy of the liver always necessary? Liver Transpl 2000; 6: 67-72.
13. Torzilli G, Minagawa M, Takayama T et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30: 889-93.
14. Kim SH, Lim HK, Lee WJ, Cho JM, Jang HJ. Needle-tract implantation in hepatocellular carcinoma: Frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 2000; 25: 246-50.
15. Amano S, Ebara M, Yajima T et al. Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 2003; 18: 273-9.
16. Ebara M, Fukuda H, Kojima Y et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 1999; 210: 81-8.
17. Numata K, Tanaka K, Kiba T et al. Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma. J Ultrasound Med 2001; 20: 89-98.
18. Wilson SR, Burns PN, Murdali D et al. Harmonic hepatic US with microbubbles contrast agents: Initial experience showing improved characterization of hemangioma, hepatocellular carcinoma and metastasis. Radiology 2000; 215: 147-51.
19. Choi BI, Kim TK, Han JK, Kim AY, Chang KS, Park JP. Vascularity of hepatocellular carcinoma: Assessment with contrast-enhanced second harmonic versus conventional power Doppler US. Radiology 2000; 214: 381-6.
20. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumor: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2001; 216: 411-17.
21. Tanaka S, Ioka T, Oshikawa O, Hamada Y, Yoshioka F. Dynamic sonography of hepatic tumors. AJR 2001; 177: 799-805.
22. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
23. Wei K, Jayaweera AR, Firoozan S et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97: 473-83.
24. Hotta N, Tagava T, Maeno T et al. Advanced dynamic flow imaging with contrast-enhanced ultrasonography for the evaluation of tumor vascularity in liver tumors. Clin Imaging 2005; 29: 34-41.
25. Solbiati L, Tonillini M, Cova L, Goldberg N. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 2001; 11 (Suppl 3): E15-26.
26. Nicolau C, Catala V, Vilana R et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14: 1092-9.
27. Fan Z-H, Chen M-H, Dai Y et al. Evaluation of primary malignancies of liver using contrast-enhanced sonography: Correlation with pathology. AJR 2006; 186: 1512-19.
28. Ding H, Kudo M, Onda H et al. Hepatocellular carcinoma: Depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology 2001; 220: 349-56.
29. Huang-Wei C, Bleuzen A, Olar M et al. Differential diagnosis of focal nodular hyperplasia with quantitative parametric analysis in contrast-enhanced sonography. Invest Radiol 2006; 41: 363-8.
30. Sugimoto K, Moriyasu F, Kamiyama N, Metoki R, Iijima H. Parametric imaging of contrast ultrasound for the evaluation of neovascularization in liver tumors. Hepatol Res 2007; 37: 464-72.
31. Ueda K, Terada T, Nakanuma Y et al. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: A morphometric study. Hum Pathol 1992; 23: 619-26.
32. Miyaaki H, Fujimoto M, Kurogi M et al. Pathomorphological study on small nodular lesions in hepatitis C virus-related cirrhosis. Oncol Rep 2005; 14: 1469-74.
33. Hisai H, Kato J, Kobune M et al. Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin Cancer Res 2003; 9: 4852-9.